Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multistage Delivery Technologies: Multifunctional, Interdisciplinary Approaches to Nanomedicine.

Literature DB >> 27198852

Multistage Delivery Technologies: Multifunctional, Interdisciplinary Approaches to Nanomedicine.

Matthew T Haynes¹, Leaf Huang¹.

Abstract

Mesh：

Year: 2016 PMID： 27198852 PMCID： PMC4881780 DOI： 10.1038/mt.2016.75

Source DB: PubMed Journal: Mol Ther ISSN： 1525-0016 Impact factor: 11.454

× No keyword cloud information.

27 in total

1. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.

Authors: Ennio Tasciotti; Xuewu Liu; Rohan Bhavane; Kevin Plant; Ashley D Leonard; B Katherine Price; Mark Ming-Cheng Cheng; Paolo Decuzzi; James M Tour; Fredika Robertson; Mauro Ferrari
Journal: Nat Nanotechnol Date: 2008-03-02 Impact factor: 39.213

2. Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.

Authors: Yang Liu; Yunxia Hu; Leaf Huang
Journal: Biomaterials Date: 2014-01-02 Impact factor: 12.479

3. Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer.

Authors: Ming-Yu Lien; Liang-Chih Liu; Hwei-Chung Wang; Ming-Hsin Yeh; Chih-Jung Chen; Su-Peng Yeh; Li-Yuan Bai; Yu-Min Liao; Chen-Yuan Lin; Ching-Yun Hsieh; Ching-Chan Lin; Long-Yuan Li; Po-Han Lin; Chang-Fang Chiu
Journal: Anticancer Res Date: 2014-12 Impact factor: 2.480

4. Cellular association and assembly of a multistage delivery system.

Authors: Rita E Serda; Aaron Mack; Merlyn Pulikkathara; Ana Maria Zaske; Ciro Chiappini; Jean R Fakhoury; Douglas Webb; Biana Godin; Jodie L Conyers; Xue W Liu; James A Bankson; Mauro Ferrari
Journal: Small Date: 2010-06-21 Impact factor: 13.281

5. An injectable nanoparticle generator enhances delivery of cancer therapeutics.

Authors: Rong Xu; Guodong Zhang; Junhua Mai; Xiaoyong Deng; Victor Segura-Ibarra; Suhong Wu; Jianliang Shen; Haoran Liu; Zhenhua Hu; Lingxiao Chen; Yi Huang; Eugene Koay; Yu Huang; Jun Liu; Joe E Ensor; Elvin Blanco; Xuewu Liu; Mauro Ferrari; Haifa Shen
Journal: Nat Biotechnol Date: 2016-03-14 Impact factor: 54.908

6. Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Authors: Teresa Coelho; David Adams; Ana Silva; Pierre Lozeron; Philip N Hawkins; Timothy Mant; Javier Perez; Joseph Chiesa; Steve Warrington; Elizabeth Tranter; Malathy Munisamy; Rick Falzone; Jamie Harrop; Jeffrey Cehelsky; Brian R Bettencourt; Mary Geissler; James S Butler; Alfica Sehgal; Rachel E Meyers; Qingmin Chen; Todd Borland; Renta M Hutabarat; Valerie A Clausen; Rene Alvarez; Kevin Fitzgerald; Christina Gamba-Vitalo; Saraswathy V Nochur; Akshay K Vaishnaw; Dinah W Y Sah; Jared A Gollob; Ole B Suhr
Journal: N Engl J Med Date: 2013-08-29 Impact factor: 91.245

Review 7. Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.

Authors: Jacob S Young; Ramin A Morshed; Julius W Kim; Irina V Balyasnikova; Atique U Ahmed; Maciej S Lesniak
Journal: Expert Opin Drug Deliv Date: 2014-07-08 Impact factor: 6.648

8. Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer.

Authors: Christine E Swenson; Lois E Bolcsak; Gerald Batist; Troy H Guthrie; Katherine H Tkaczuk; Harold Boxenbaum; Lauri Welles; Shein-Chung Chow; Rupinder Bhamra; Philip Chaikin
Journal: Anticancer Drugs Date: 2003-03 Impact factor: 2.248

Multistage Delivery Technologies: Multifunctional, Interdisciplinary Approaches to Nanomedicine.

1. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.

2. Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.

3. Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer.

4. Cellular association and assembly of a multistage delivery system.

5. An injectable nanoparticle generator enhances delivery of cancer therapeutics.

6. Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Review 7. Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.

8. Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancer.

9. Principles of nanoparticle design for overcoming biological barriers to drug delivery.

10. Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.

1. Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy.

2. Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents.